K. Robison

发表

Gender Differences in Scholarly Productivity Within Academic Gynecologic Oncology Departments

J. Eloy, P. Svider, E. Hill, 2015, Obstetrics and gynecology.

Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients.

K. Robison, R. Bristow, D. Mukamel, 2017, Contemporary clinical trials.

Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.

Richard G. Moore, K. Robison, Rakesh K. Singh, 2011, Gynecologic oncology.

Opportunities for Early Detection of Endometrial Cancer in Women With Postmenopausal Bleeding.

K. Robison, V. Jacoby, K. Matteson, 2018, JAMA internal medicine.

Update on the chemotherapeutic management of endometrial cancer.

K. Robison, D. Dizon, A. Bregar, 2014, Clinical advances in hematology & oncology : H&O.

Cervical Cancer Prevention: Screening Among Undocumented Hispanic Women Compared With Documented Hispanic Women.

C. Raker, K. Robison, Naaman Mehta, 2020, Journal of lower genital tract disease.

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

K. Robison, A. Okamoto, L. Molinero, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers.

C. Raker, K. Robison, A. Stuckey, 2019, Gland surgery.

The Association Between Mindfulness and Post-operative Pain: A Prospective Cohort Study of Gynecologic Oncology Patients Undergoing Minimally Invasive Hysterectomy.

C. Raker, K. Robison, C. Mathews, 2020, Journal of minimally invasive gynecology.

Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals

K. Robison, A. Stuckey, Vrishali V. Lopes, 2016, American journal of clinical oncology.

The effects of age on treatment and outcomes in women with stages IB1-IIB cervical cancer.

Dario R. Roque, K. Robison, D. Dizon, 2013, Journal of geriatric oncology.

A Case of Peutz-Jeghers Syndrome With Breast Cancer, Bilateral Sex Cord Tumor With Annular Tubules, and Adenoma Malignum Caused by STK11 Gene Mutation

Richard G. Moore, K. Robison, M. Steinhoff, 2008, International Journal of Gynecologic Cancer.

Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women

C. Raker, K. Robison, M. Clark, 2015, Obstetrics and gynecology.

Ready for the robot? A cross-sectional survey of OB/GYN fellowship directors’ experience and expectations of their incoming fellow’s robotic surgical skills

C. Raker, K. Robison, K. Wohlrab, 2020, Journal of Robotic Surgery.

While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity

K. Robison, P. DiSilvestro, V. Danilack, 2018, American journal of obstetrics and gynecology.

LBA31 Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)

K. Robison, L. Molinero, S. Pignata, 2020 .

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.

Steven J Skates, Richard G. Moore, R. Bast, 2010, American journal of obstetrics and gynecology.

Opioid use after minimally invasive hysterectomy in gynecologic oncology patients.

C. Raker, K. Robison, C. Mathews, 2019, Gynecologic oncology.

Outcomes for Women Receiving Bevacizumab for Treatment of Ovarian Cancer Versus Other Solid Tumors at an Academic Oncology Center

K. Robison, A. Stuckey, D. Dizon, 2013 .

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study

B. Monk, K. Robison, L. Ramondetta, 2020, International Journal of Gynecological Cancer.

Sentinel Lymph Node Biopsy in Vulvar Cancer: What is the Standard of Care?

K. Robison, Lindsey Beffa, 2017 .

Vulvar cancer and sentinel lymph nodes: a new standard of care?

Richard G. Moore, K. Robison, S. Fiascone, 2014, Expert review of anticancer therapy.

Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma

Dario R. Roque, C. Raker, K. Robison, 2015, International Journal of Gynecologic Cancer.

Superficial versus deep inguinal nodal dissection for vulvar cancer staging.

E. Hill, J. Emerson, K. Robison, 2022, Gynecologic oncology.

Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone.

Dario R. Roque, Richard G. Moore, K. Robison, 2014, Gynecologic oncology.

Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.

Richard G. Moore, K. Robison, W. Gajewski, 2006, Gynecologic oncology.

Prevalence of HPV and Type Distribution in Southeast Asian Women Residing in Rhode Island

C. Raker, K. Robison, M. Clark, 2014 .

Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement.

K. Robison, B. Whitcomb, M. Pearl, 2020, Gynecologic oncology.

Pelvic floor disorders in women with gynecologic malignancy

K. Robison, K. Wohlrab, E. Hall, 2018, Current opinion in obstetrics & gynecology.

Sexual health and function among patients receiving systemic therapy for primary gynecologic cancers.

C. Raker, K. Robison, A. Kulkarni, 2022, Gynecologic oncology.

Cervical cancer prevention: Asian-American women's knowledge and participation in screening practices.

M. Clark, C. Raker, K. Robison, 2014, Women's health issues : official publication of the Jacobs Institute of Women's Health.

Utility of Tumor Marker HE4 to Predict Depth of Myometrial Invasion in Endometrioid Adenocarcinoma of the Uterus

Richard G. Moore, K. Robison, G. Lambert-Messerlian, 2011, International Journal of Gynecologic Cancer.

Gastric-Type Endometrial Adenocarcinoma: Report of Two Cases in Patients From the United States

K. Robison, K. Rojas, C. Mathews, 2018, International journal of surgical pathology.

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

Danielle M. Enserro, J. Blay, K. Robison, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gynecologic Surgical Outcomes Through the Patient's Eyes: Are Physicians Looking in the Same Direction?

J. Emerson, K. Robison, R. Sangha, 2019, Obstetrical & gynecological survey.

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Yurii B. Shvetsov, K. Robison, S. Franceschi, 2019, The Lancet. Infectious diseases.

Update on sentinel lymph node evaluation in gynecologic malignancies

Richard G. Moore, K. Robison, L. L. Holman, 2011, Current opinion in obstetrics & gynecology.

Salpingectomy for Sterilization: A New Standard of Care?

K. Robison, Karen R. Browning, V. Flores, 2015 .

Family planning in carriers of BRCA1 and BRCA2 pathogenic variants

C. Raker, K. Robison, A. Stuckey, 2021, Journal of genetic counseling.

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.

K. Robison, A. Stuckey, R. Legare, 2012, Gynecologic oncology.

Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer: Is There a Role for Maintenance Therapy?

Richard G. Moore, C. Raker, K. Robison, 2013 .

Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study.

Danielle M. Enserro, J. Blay, K. Robison, 2018 .

Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia

C. Raker, K. Robison, M. Clark, 2018, Journal of lower genital tract disease.

Effect of a Vitamin D3 derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model

C. Raker, K. Robison, A. Stuckey, 2010, Investigational New Drugs.

Advance care planning as a shared endeavor: completion of ACP documents in a multidisciplinary cancer program

Miles Q. Ott, Susan C. Miller, K. Robison, 2017, Psycho-oncology.

Financial toxicity in BRCA1 and BRCA2 carriers.

C. Raker, K. Robison, A. Stuckey, 2023, Gynecologic oncology.

Understanding Women's Sexual Behaviors That May Put Them at Risk for Human Papillomavirus–Related Neoplasias: What Should We Ask?

C. Raker, K. Robison, A. Kulkarni, 2017, Journal of lower genital tract disease.

Sensation of Pain Using Buffered Lidocaine for Infiltration Before Vulvar Biopsy: A Randomized Controlled Trial.

C. Raker, K. Robison, A. Kulkarni, 2020, Obstetrics and gynecology.

Deadly Legacy-The 510(k) Path to Medical Device Clearance.

K. Robison, E. Adashi, I. Cohen, 2021, JAMA surgery.

Sentinel Lymph Node Evaluation in Vulvar Cancer: The New Standard of Care

K. Robison, M. Kole, 2016 .

Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.

Richard G. Moore, K. Robison, P. DiSilvestro, 2008, Gynecologic oncology.

Gender and the Balance of Parenting and Professional Life among Gynecology Subspecialists.

E. Hill, C. Raker, K. Robison, 2018, Journal of minimally invasive gynecology.

Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

K. Robison, P. Goodfellow, D. Mutch, 2015, Gynecologic oncology.

The accuracy of surgeons' provided estimates for the duration of hysterectomies: a pilot study.

C. Raker, K. Robison, G. Wharton, 2015, Journal of minimally invasive gynecology.

Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.

C. Raker, K. Robison, C. Sung, 2016, Gynecologic oncology.

Screening adolescents and young women.

K. Robison, L. Boardman, 2013, Obstetrics and gynecology clinics of North America.

Evaluation of sentinel lymph nodes in vulvar, endometrial and cervical cancers

J. Emerson, K. Robison, 2016 .

A change in the balance between personal and professional life among female gynecologic oncologists

E. Hill, C. Raker, K. Robison, 2017 .

Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care

M. Clark, C. Raker, K. Robison, 2023, Journal of Assisted Reproduction and Genetics.

Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?

Richard G. Moore, K. Robison, R. Strongin, 2019, Gynecologic oncology.

Characterization of Patients with Endometrial Cancer and Low-Volume Nodal Disease

Richard G. Moore, K. Robison, K. Underkofler, 2023, Obstetrics & Gynecology: Open Access.

Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers

C. Raker, K. Robison, A. Stuckey, 2023, Menopause.